Opinion
Video
Author(s):
Panelists discuss how health care teams can ensure patients remain on optimal low-density lipoprotein cholesterol (LDL-C)–lowering therapy by leveraging collaborative strategies, facilitating therapy intensification, and incorporating essential components into shared decision-making tools to personalize treatment plans.
Optimizing LDL-C Management in Clinical Practice
Strategies for Ensuring Optimal LDL-C–Lowering Therapy
Systematic monitoring: Implement regular lipid panel follow-ups and automated reminders in electronic medical record systems to identify patients not meeting LDL-C target levels
Risk stratification: Prioritize therapy intensification based on atherosclerotic cardiovascular disease (ASCVD) risk factors and comorbidities to focus on high-risk patients requiring more aggressive intervention
Algorithm-based approaches: Develop clear clinical pathways and decision trees for therapy escalation that can be implemented by the entire health care team
Team-based care models: Utilize pharmacists, nurse practitioners, and care coordinators for medication reconciliation, adherence monitoring, and protocol-driven therapy adjustments
Facilitating Therapy Intensification Through Collaboration
Essential Components for Shared Decision-Making Tools
Cultural adaptations: Decision aids that address cultural beliefs and preferences about medication use and cardiovascular risk management
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.